Steroid-related mechanisms in ocular health and disease: therapeutic effects, adverse events, and stress-related modulators. A narrative literature overview

• by Fabio Scarinci, Giulio Pocobelli, Francesca Romana Patacchioli

• July 3, 2026

Red-green disease: overreliance on color-coded OCT RNFL analysis in glaucoma diagnosis

• by Venkata S. Jonnakuti, Misha F. Syed, Praveena Gupta

• June 10, 2026

Case Report: Successful treatment of pyoderma gangrenosum-like granulomatous liver disease without skin lesions using a TNF-alpha inhibitor

• by Isabelle Panne, Matthias Matter, Jürg Vosbeck, Matthias von Rotz, Alexandra Steinemann, Marten Trendelenburg, Markus H. Heim, Peter Schirmacher, Andrea De Gottardi, Ansgar W. Lohse, Luigi M. Terracciano, Christine Bernsmeier

• June 15, 2026

FDA Clears Nocturnal IOP Device

Balance Ophthalmics gains FDA 510(k) clearance for wireless FSYX glaucoma device

• May 26, 2026

• 2 min